Nifty500: 248 stocks have more upside; Sun Pharma, RITES 'overbought'

Sun Pharmaceutical Industries is the only other stock among the Sensex 30 and Nifty 50 that trades in the overbought category, technically.

stock market, markets, trading, nse, bse, sensex, nifty, rally
Bullish rally
Avdhut Bagkar Mumbai
2 min read Last Updated : Oct 18 2022 | 12:40 PM IST
Bulls were seen roaring on Tuesday with the BSE Sensex and NSE Nifty 50 topping 1 per cent rise and scaling their respective significant resistances of 59,000 and 17,500-levels. On Monday too the key benchmark indices had logged firm gains.
 
Technically, overcoming of key resistances after a brief period of sideway movement points towards a positive trigger. The BSE Sensex and Nifty have thus far climbed 2 per cent in the last two trading sessions on a weekly scale; such move was last seen in August 2022 that further accelerated into an additional 1.7 per cent gain. 

Such a similar positive move can emerge this time too, as currenly only 10 stocks in the Nifty 500 index trade in the overbought category. Altogether, 258 stocks are trading over their 200-day moving average (DMA), thus indicating over half of Nifty 500 stocks are on the bull radar. 

Whenever, a stock conquers the 200-DMA mark, the sentiment ought to turn bullish as investors see this scenario as a shift in momentum. They prefer to bet on such inclusive stocks as a 200-DMA cushion builts support base in the short-term.

Sun Pharmaceutical Industries is the only stock among the BSE Sensex 30 and the Nifty 50 constituents' that trades in the overbought category of the Relative Strength Index (RSI).

Federal Bank, among Nifty Mid-cap stocks and Deepak Fertilisers & Petrochemicals Corp, IDFC trade in the overbought condition. 

Thus, only if 10 stocks in the Nifty 500 index trades in the overbought condition, the remaining 248 stocks holding above the 200-DMA are yet to rise more to hit this overbought mark. When benchmark indices succeed to defend ground over their key hurdles, the trend could bolster stocks to rally with a decisive trend. 

An upside moves of 15-20 per cent cannot be ruled out before stocks hit the upper roof of the overhead sentiment.

Sources: spidersoftwareindia

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Sun PharmaBuzzing stocksMazagon Dockstock market tradingMarkets Sensex NiftyTrading strategiesMarket technicalsMarket trendsStock RecommendationsRites Ltdtechnical charts

Next Story